These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


167 related items for PubMed ID: 6094357

  • 21. The mitogenic effect of the lymphocytosis promoting factor from Bordetella pertussis on human lymphocytes.
    Morse JH, Kong AS, Lindenbaum J, Morse SI.
    J Clin Invest; 1977 Sep; 60(3):683-92. PubMed ID: 197121
    [Abstract] [Full Text] [Related]

  • 22. STUDIES ON THE LYMPHOCYTOSIS INDUCED IN MICE BY BORDETELLA PERTUSSIS.
    MORSE SI.
    J Exp Med; 1965 Jan 01; 121(1):49-68. PubMed ID: 14253487
    [Abstract] [Full Text] [Related]

  • 23. Antibody responses after vaccination and disease against leukocytosis promoting factor, filamentous hemagglutinin, lipopolysaccharide and a protein binding to complement-fixing antibodies induced during whooping cough.
    Winsnes R, Lønnes T, Møgster B, Berdal BP.
    Dev Biol Stand; 1985 Jan 01; 61():353-65. PubMed ID: 2872124
    [Abstract] [Full Text] [Related]

  • 24. Leukocytosis-promoting factor of Bordetella pertussis. 3. Its identity with protective antigen.
    Sato Y, Arai H, Suzuki K.
    Infect Immun; 1974 May 01; 9(5):801-10. PubMed ID: 4363229
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Activation of the respiratory burst in murine phagocytes by certain guanine ribonucleosides modified at the 7 and 8 positions: possible involvement of a pertussis toxin-sensitive G-protein.
    Ojo-Amaize EA, Rubalcava B, Avery TL, Cottam HB, Matsumoto SS, Jolley WB, Robins RK.
    Immunol Lett; 1990 Jan 01; 23(3):173-8. PubMed ID: 2106487
    [Abstract] [Full Text] [Related]

  • 29. The in vitro effects of Bordetella pertussis lymphocytosis-promoting factor on murine lymphocytes: II. Nature of the responding cells.
    Kong AS, Morse SI.
    J Exp Med; 1977 Jan 01; 145(1):163-74. PubMed ID: 187716
    [Abstract] [Full Text] [Related]

  • 30. Assay of pertussis vaccine reactivity factors by measurement of the paw swelling response, endotoxin and histamine-sensitizing factor.
    Vuolo AM, Lustigman B.
    Biologicals; 1993 Mar 01; 21(1):45-52. PubMed ID: 8217117
    [Abstract] [Full Text] [Related]

  • 31. Enhancement of suppressor T cell activity by lymphocyte promoting factor of Bordetella pertussis.
    Huang SW.
    Immunopharmacol Immunotoxicol; 1990 Mar 01; 12(1):61-76. PubMed ID: 2141034
    [Abstract] [Full Text] [Related]

  • 32. Leukocytosis-promoting factor of Bordetella pertussis. II. Biological properties.
    Sato Y, Arai H, Suzuki K.
    Infect Immun; 1973 Jun 01; 7(6):992-9. PubMed ID: 4351972
    [Abstract] [Full Text] [Related]

  • 33. Bordetella Adenylate Cyclase Toxin Inhibits Monocyte-to-Macrophage Transition and Dedifferentiates Human Alveolar Macrophages into Monocyte-like Cells.
    Ahmad JN, Holubova J, Benada O, Kofronova O, Stehlik L, Vasakova M, Sebo P.
    mBio; 2019 Sep 24; 10(5):. PubMed ID: 31551332
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Biological activities of crystalline pertussigen from Bordetella pertussis.
    Munoz JJ, Arai H, Bergman RK, Sadowski PL.
    Infect Immun; 1981 Sep 24; 33(3):820-6. PubMed ID: 6269999
    [Abstract] [Full Text] [Related]

  • 36. Reovirus transport--studies using lymphocytosis promoting factor.
    Sugimoto M, Sharpe AH, Sato Y, Greene MI, Fields BN.
    Pathobiology; 1990 Sep 24; 58(4):185-92. PubMed ID: 2174674
    [Abstract] [Full Text] [Related]

  • 37. Inhibition of monocyte oxidative responses by Bordetella pertussis adenylate cyclase toxin.
    Pearson RD, Symes P, Conboy M, Weiss AA, Hewlett EL.
    J Immunol; 1987 Oct 15; 139(8):2749-54. PubMed ID: 2888823
    [Abstract] [Full Text] [Related]

  • 38. Novel biological property of pertussis toxin: chemotactic activity on human monocytes.
    Ogawa T, Takada H, Kotani S, Sato H, Sato Y.
    Infect Immun; 1983 Jul 15; 41(1):420-2. PubMed ID: 6305846
    [Abstract] [Full Text] [Related]

  • 39. Natural history of pertussis antibody in the infant and effect on vaccine response.
    Van Savage J, Decker MD, Edwards KM, Sell SH, Karzon DT.
    J Infect Dis; 1990 Mar 15; 161(3):487-92. PubMed ID: 2313127
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.